Topical application of dynorphin A (1-17) antibodies attenuates neuronal nitric oxide synthase up-regulation, edema formation, and cell injury following focal trauma to the rat spinal cord-Reference-Cited by-同舟云学术

Topical application of dynorphin A (1-17) antibodies attenuates neuronal nitric oxide synthase up-regulation, edema formation, and cell injury following focal trauma to the rat spinal cord

Published: Issue: Volume: Page:309-315
ISSN:
Container-title:Brain Edema XIII
language:
Short-container-title:

Author:

Sharma H. S.,Nyberg F.,Gordh T.,Alm P.

Publisher

Springer-Verlag

Link

http://link.springer.com/content/pdf/10.1007/3-211-30714-1_66.pdf

Reference40 articles.

1. Azbill RD, Mu X, Bruce-Keller AJ, Mattson MP, Springer JE (1997) Impaired mitochondrial function, oxidative stress and altered antioxidant enzyme activities following traumatic spinal cord injury. Brain Res 765: 283–290

2. Chavkin C, Goldstein A (1981) Specific receptors for the opioid peptide dynorphin: structure-activity relationships. Proc Natl Acad Sci USA 78: 6543–6547

3. Chen L, Gu Y, Huang LY (1995) The opioid peptide dynorphin directly blocks NMDA receptor channels in the rat. J Physiol 482: 575–581

4. Cho HJ, Basbaum AI (1989) Ultratstructural analysis of dynorphin B-immunoreactive cells and terminals in the superficial dorsal horn of the deafferented spinal cord of the rat. J Comp Neurol 281: 193–201

5. Faden AI (1990) Opioid and non-opioid mechanisms may contribute to dynorphin’s pathophysiological actions in the spinal cord injury. Ann Neurol 27: 64–74

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanodelivery of histamine H3 receptor inverse agonist BF-2649 with H3 receptor antagonist and H4 receptor agonist clobenpropit induced neuroprotection is potentiated by antioxidant compound H-290/51 in spinal cord injury;Nanowired Delivery of Drugs and Antibodies for Neuroprotection in Brain Diseases with Co-Morbidity Factors Part B;2023

2. Preface;International Review of Neurobiology;2023

3. Neuroprotective Effects of Nanowired Delivery of Cerebrolysin with Mesenchymal Stem Cells and Monoclonal Antibodies to Neuronal Nitric Oxide Synthase in Brain Pathology Following Alzheimer’s Disease Exacerbated by Concussive Head Injury;Advances in Neurobiology;2023

4. Neuroprotective effects of insulin like growth factor-1 on engineered metal nanoparticles Ag, Cu and Al induced blood-brain barrier breakdown, edema formation, oxidative stress, upregulation of neuronal nitric oxide synthase and brain pathology;Progress in Brain Research;2021

5. Histamine H3 and H4 receptors modulate Parkinson's disease induced brain pathology. Neuroprotective effects of nanowired BF-2649 and clobenpropit with anti-histamine-antibody therapy;Progress in Brain Research;2021